कृपया अन्य खोज का प्रयास करें
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company’s lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer’s disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer’s disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer’s disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich’s ataxia; and GBA1 gene replacement to treat parkinson’s disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington’s disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michael J. Higgins | 62 | 2015 | Independent Chairman of the Board |
Glenn F. Pierce | 68 | 2017 | Independent Director |
James Arthur Geraghty | 70 | 2014 | Independent Director |
Steven E. Hyman | 72 | 2015 | Independent Director |
Alfred W. Sandrock | 66 | 2022 | President, CEO & Director |
Nancy Vitale | 53 | 2020 | Independent Director |
Grace E. Colon | 57 | 2023 | Independent Director |
Catherine J. Mackey | 69 | 2022 | Independent Director |
Dinah Sah | 63 | 2014 | Consultant & Member of Scientific Advisory Board |
George A. Scangos | 76 | 2023 | Director |
Phillip D. Zamore | - | - | Founder & Member of Scientific Advisory Board |
Jude Onyia | 60 | 2023 | Director |
Guangping Gao | - | - | Founder & Member of Scientific Advisory Board |
David Liu | - | - | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है